1-Minute Consult

Can patients opt to turn off implantable cardioverter-defibrillators near the end of life?

M. Motaz Baibars, MD, M. Chadi Alraies, MD, FACP, Amjad Kabach, MD and Marc Pritzker, MD, FACC
Cleveland Clinic Journal of Medicine February 2016, 83 (2) 97-98; DOI: https://doi.org/10.3949/ccjm.83a.15007

Article Information

vol. 83 no. 2 97-98
DOI 
https://doi.org/10.3949/ccjm.83a.15007
PubMed 
26871383
Published By 
Cleveland Clinic Journal of Medicine
Print ISSN 
0891-1150
Online ISSN 
1939-2869
History 
  • Published online February 1, 2016.
Copyright & Usage 
Copyright © 2016 The Cleveland Clinic Foundation. All Rights Reserved.

Author Information

  1. M. Motaz Baibars, MD
  1. Department of Hospital Medicine, Peninsula Regional Medical Center, Salisbury, MD
  1. M. Chadi Alraies, MD, FACP⇑
  1. Department of Medicine, Cardiovascular Division, University of Minnesota, Minneapolis
  1. ADDRESS:
    M. Chadi Alraies, MD, FACP, Department of Medicine, Cardio-vascular Division, University of Minnesota Medical Center, 420 Delaware Street SE, MMC 508, Minneapolis, MN 55455; e-mail: alrai005{at}umn.edu
  1. Amjad Kabach, MD
  1. Department of Medicine, Creighton University, Omaha, NE
  1. Marc Pritzker, MD, FACC
  1. Director, Pulmonary Hypertension Service, University of Minnesota, Minneapolis
  2. Professor of Medicine, Surgery and Biomedical Innovation

Cited By...

Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Subjects